Streetbeat News

Stock Prices

BYRN

EVEX

LICN

NVVE

RAYA

SMXT

SRFM

TTEC

XPON

In Monday's pre-market session, TTEC Holdings, Eve Holding, and SolarMax Technology saw significant stock price increases, while Expion360, Erayak Power Solution, Byrna Technologies, Lichen China, Surf Air Mobility, and Nuvve Holding experienced declines.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 12:06 pm

EJH

KAVL

KXIN

MRM

NIO

ZCMD

In Monday's pre-market session, several consumer discretionary stocks experienced significant movements. Kaixin Holdings (KXIN) and ZHONGCHAO (ZCMD) saw substantial gains, while MEDIROM Healthcare Techs (MRM) and Kaival Brands Innovations (KAVL) experienced declines.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 12:06 pm

ADXN

ANAB

BNOX

BWAY

CRVS

ENSC

ESLA

PRME

PTIX

THAR

TRAW

VERO

In Monday's pre-market session, several healthcare stocks experienced significant movements. Prime Medicine, Traws Pharma, and Tharimmune saw notable gains, while Ensysce Biosciences and Corvus Pharma faced declines. Earnings reports influenced some stock movements.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 12:06 pm

BTDR

EMKR

NA

OCFT

In Monday's pre-market session, several information technology stocks experienced significant movements. EMCORE (EMKR) saw a remarkable 132.2% increase, while OneConnect Financial Tech (OCFT) rose by 16.75%. On the downside, Nano Labs (NA) decreased by 12.0%, and Bitdeer Technologies (BTDR) fell by 9.6%.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 12:06 pm

AGCO

TAFE, the largest shareholder of AGCO Corporation with a 16.3% stake, has issued a letter to fellow shareholders advocating for changes in AGCO's board and strategy. TAFE believes these changes are necessary due to AGCO's strategic missteps and loss of market share. TAFE emphasizes its commitment to unlocking AGCO's potential and suggests a strategic transformation with new independent directors.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:06 pm

SHIP

Seanergy Maritime Holdings Corp. (NASDAQ:SHIP) is urging shareholders to vote in favor of its director nominees and against proposals by George Economou, who seeks control over the company's board. Seanergy emphasizes its commitment to delivering shareholder value and warns that Economou's track record could harm the company.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:05 pm

HSDT

Helius Medical Technologies has reported preliminary results from its PoNSTEP study, indicating that adherence to PoNS therapy improves gait deficits in multiple sclerosis patients. Full results are expected by early 2025.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:05 pm

NRBO

NeuroBo Pharmaceuticals announced positive top-line results from Part 1 of its Phase 1 trial for DA-1726, a treatment for obesity. The results showed favorable safety and dose-linear pharmacokinetics. Part 2 data is expected in Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:04 pm

MDGL

Madrigal Pharmaceuticals announced positive results from the Phase 3 MAESTRO-NASH trial of Rezdiffra, showing significant improvements in health-related quality of life for NASH patients. Rezdiffra, the first FDA-approved NASH treatment, demonstrated efficacy in improving fibrosis and NASH resolution.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:03 pm

OCUP

Ocuphire Pharma announced the publication of full Phase 3 trial results for RYZUMVI, a treatment for pharmacologically-induced mydriasis. The trials showed significant efficacy and a favorable safety profile, with rapid reversal of pupil dilation.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 12:02 pm